Get started
Author

Varenka J. Barbero-Becerra

Observed names: Barbero-Becerra V.J., Barbero-Becerra, V.J., Barbero-Becerra, Varenka, V. Barbero-Becerra, V. J. Barbero-Becerra, V.J. Barbero Becerra, V.J. Barbero-Becerra, Varenka Barbero Becerra, Varenka Barbero-Becerra, Varenka J Barbero-Becerra, Varenka J Barbero‐Becerra, Varenka J. Barbero Becerra, Varenka J. Barbero-becerra, Varenka Julieta Barbero Becerra, Varenka Julieta Barbero-Becerra
Observed institutions: Mexican Social Security Institute, Universidad Autónoma Metropolitana, AREA Science Park, Fondazione Italiana Fegato, Hospital Infantil de México Federico Gómez, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Hospital Médica Sur, Centro Medico Nacional Siglo XXI
ORCID: 0000-0001-6660-9108
Observed ORCID: 0000-0001-6660-9108
OpenAlex ID: A5075594499
Role of bioactive fatty acids in nonalcoholic fatty liver disease
2015 · Eva Juárez-Hernández, Norberto C. Chávez-Tapia, et al. · Nutrition Journal · 140
PDF
The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH
2015 · Varenka J. Barbero-Becerra, Pablo J. Giraudi, et al. · Toxicology in Vitro · 74
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
2023 · Andrea del Carmen Maldonado-Rojas, Julia María Zuarth-Vázquez, et al. · Annals of Hepatology · 58
The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation
2014 · Pablo J. Giraudi, Varenka J. Barbero Becerra, et al. · Experimental and Molecular Pathology · 54
Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
2023 · Alejandra Mijangos-Trejo, Natalia Nuño-Lambarri, et al. · International Journal of Molecular Sciences · 53
PDF
Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level
2022 · Carlos Pérez-Monter, Alejandro Álvarez-Arce, et al. · International Journal of Molecular Sciences · 53
PDF
Current evidence on the use of probiotics in liver diseases
2015 · Norberto C. Chávez-Tapia, Leticia González-Rodríguez, et al. · Journal of Functional Foods · 38
Biomarkers in hepatocellular carcinoma: an overview
2017 · Eva Juárez-Hernández, Daniel Motola-Kuba, et al. · Expert Review of Gastroenterology & Hepatology · 34
Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach
2016 · Natalia Nuño-Lámbarri, Varenka Barbero-Becerra, et al. · International Journal of Molecular Sciences · 32
PDF
Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico
2022 · Emmanuel Aguilar-Zamora, Bart C. Weimer, et al. · Frontiers in Microbiology · 29
PDF
Mechanisms Involved in the Protective Effects of Metformin Against Nonalcoholic Fatty Liver Disease
2012 · V. J. Barbero-Becerra, J. J. Santiago-Hernandez, et al. · Current Medicinal Chemistry · 24
Punica granatum L.-derived omega-5 nanoemulsion improves hepatic steatosis in mice fed a high fat diet by increasing fatty acid utilization in hepatocytes
2020 · K. Zamora-López, L. G. Noriega, et al. · Scientific Reports · 23
PDF
Liver toxicity mechanisms of herbs commonly used in Latin America
2017 · Sofía López-Gil, Natalia Nuño-Lámbarri, et al. · Drug Metabolism Reviews · 20
Elevated cholesterol levels have a poor prognosis in a cholestasis scenario
2016 · Natalia Nuño‐Lámbarri, Varenka J Barbero‐Becerra, et al. · Journal of Biochemical and Molecular Toxicology · 14
Clostridioides Difficile in Latin America: An Epidemiological Overview
2023 · Claudia G Morales-Olvera, Lorena Lanz-Zubiría, et al. · Current Microbiology · 13
Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind, multicentre, placebo controlled, randomised clinical trial
2021 · Adriana Fabiola Romano-Munive, J Jesus García-Correa, et al. · BMJ Open Gastroenterology · 13
PDF
Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients
2020 · Fabiola López-Bautista, Varenka J. Barbero-Becerra, et al. · Annals of Hepatology · 13
PDF
Hepatic schistosomiasis as a determining factor in the development of hepatic granulomas and liver fibrosis: a review of the current literature
2024 · Lara-Cano R, Castañeda-Méndez P.F., et al. · Pathogens and Global Health · 11
PDF
Sarcopenia in chronic liver diseases: a translational overview
2020 · Varenka J. Barbero-Becerra, Iván López-Méndez, et al. · Expert Review of Gastroenterology & Hepatology · 11
Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
2024 · Ana Paula Madariaga Traconis, Misael Uribe-Esquivel, et al. · Cells · 10
PDF
La importancia de la farmacovigilancia intrahospitalaria en la detección oportuna de los errores de medicación
2018 · Francisco Villegas, David Figueroa-Montero, et al. · Gaceta Médica de México · 9
PDF
G protein-coupled receptors: Key molecules in metabolic associated fatty liver disease development
2020 · Iván López-Méndez, Karla Méndez-Maldonado, et al. · Nutrition Research · 7
Primary prophylaxis with ciprofloxacin in cirrhotic patients with ascites: a randomized, double blind study
2014 · Félix Téllez-Ávila, José Sifuentes-Osornio, et al. · Annals of Hepatology · 7
Alcohol effects on liver diseases: good or bad buddy?
2012 · Varenka J. Barbero-Becerra, Jorge A. López-Velázquez, et al. · Annals of Hepatology · 5
PDF
Inulin as a Clinical Therapeutic Intervention in Metabolic Associated Fatty Liver Disease
2021 · Varenka Barbero-Becerra, Eva Juárez-Hernández, et al. · Food Reviews International · 4
Works count: 41
Citation count: 760
H-index: 14
I10-index: 20
Year
Topic
Type